Xingxing Zang
Albert Einstein College of Medicine(US)Montefiore Medical Center(US)Northeast Agricultural University(CN)Cancer Clinic(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, CAR-T cell therapy research, Immune cells in cancer
Most-Cited Works
- → BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1(2003)864 cited
- → Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway(2014)832 cited
- → Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy(2016)559 cited
- → Molecular Features of Cancer-associated Fibroblast Subtypes and their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy Resistance(2021)415 cited
- → B7x: A widely expressed B7 family member that inhibits T cell activation(2003)410 cited
- → B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome(2007)397 cited